Vulvar Cancer Clinical Trials

30 recruiting

Frequently Asked Questions

Common questions about Vulvar Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Phase 2

Electrochemotherapy for Recurrent Vulvar Cancer

Vulvar CancerRecurrent Vulvar Cancer
Institute of Oncology Ljubljana13 enrolled1 locationNCT07443475
Recruiting
Phase 1Phase 2

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Cervical CancerAnal CancerPenile Cancer+14 more
Christian Hinrichs15 enrolled2 locationsNCT05639972
Recruiting

DESTINY-PANTUMOUR04

Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled15 locationsNCT07124000
Recruiting
Not Applicable

NODE (groiN ultrasOunD cancEr)

Lymph Node MetastasisUltrasound Therapy; ComplicationsVulvar Cancer Stage Ib+2 more
Queensland Centre for Gynaecological Cancer30 enrolled5 locationsNCT06264167
Recruiting

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

Ovarian CancerCervical CancerEndometrial Cancer+2 more
University Hospital Tuebingen120 enrolled1 locationNCT05914974
Recruiting
Not Applicable

STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision

Vulvar Cancer
British Columbia Cancer Agency249 enrolled1 locationNCT05576831
Recruiting
Early Phase 1

[177Lu]Lu-AKIR001 First-in-human Study

Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital15 enrolled1 locationNCT06639191
Recruiting

The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer

Cervical CancerEndometrial CancerIndocyanine Green (ICG)+1 more
Cukurova University30 enrolled1 locationNCT07380698
Recruiting

Cancer Loyalty Card Study 2 (CLOCS-2)

Liver CancerPancreatic CancerOvarian Cancer+7 more
Imperial College London2,900 enrolled1 locationNCT06447064
Recruiting
Not Applicable

Image-Guided Gynecologic Brachytherapy

Cervical CancerBladder CancerUterine Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins54 enrolled1 locationNCT02993900
Recruiting
Phase 2

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Dana-Farber Cancer Institute32 enrolled2 locationsNCT06677190
Recruiting
Phase 1

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Stage II Vulvar Cancer AJCC v8Stage III Vulvar Cancer AJCC v8Stage IIIA Vulvar Cancer AJCC v8+3 more
M.D. Anderson Cancer Center25 enrolled1 locationNCT04169763
Recruiting
Phase 2

Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy

Recurrent Vulvar CancerPersistent Vulvar CancerMetastatic Vulva Cancer+1 more
AGO Research GmbH42 enrolled15 locationsNCT05903833
Recruiting
Not Applicable

Serial MRI Scans During Radiation Therapy

Esophageal CancerProstate CancerMRI+5 more
Dana-Farber Cancer Institute149 enrolled2 locationsNCT04188535
Recruiting
Not Applicable

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Ovarian CancerCervical CancerEndometrial Cancer+3 more
Ira Winer70 enrolled1 locationNCT06339827
Recruiting
Phase 2

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Ovarian NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms+3 more
Yonsei University198 enrolled18 locationsNCT06023862
Recruiting
Not Applicable

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

Cervical CancerAnal CancerVulvar Cancer+4 more
Dr. Danielle Vicus110 enrolled1 locationNCT03061435
Recruiting
Not Applicable

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Cervical CancerEndometrial CancerUterine Cancer+4 more
Northwestern University192 enrolled1 locationNCT05743517
Recruiting
Phase 2

Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies

Cervical CancerEndometrial CancerVaginal Cancer+4 more
University of Utah68 enrolled1 locationNCT05979610
Recruiting
Phase 2

AK104 for Recurrent or Metastatic Vulvar Cancer

Vulvar Cancer
Akeso20 enrolled6 locationsNCT05932212